October 15, 2025
Grant award provides MD/PhD candidates with funding and expertise to translate promising scientific discoveries into medicines October 15, 2025, CLEVELAND, OH – Harrington Discovery Institute at University Hospitals and Case Western Reserve University School of Medicine have issued a call for proposals for the 2026...
Continue ReadingSeptember 23, 2023
Agreement enables the development of therapeutics, including AcuraStem's AS-202 Candidate, an antisense oligonucleotide that suppresses levels of the PIKFYVE kinase Continue Reading
September 14, 2023
New gene therapy company created and funded by Oxford Science Enterprises, Harrington Discovery Institute and Old College Capital in partnership with six leading scientists from the world-renowned UK Respiratory Gene Therapy Consortium (GTC) Continue Reading
September 14, 2023
Cell therapies derived from stem cells could one day prevent vision loss or even restore sight in retinal degenerative disease. Continue Reading
August 22, 2023
A Conversation with Jonathan S. Stamler, MD, President of Harrington Discovery Institute Continue Reading
July 05, 2023
New Orleans, LA – LSU Health New Orleans today announced that has exercised its option to receive an exclusive license to certain early-stage technology designed to slow the progression of DNA repeat expansion disorders.In DNA repeat expansion disorders, a segment of repeated DNA expands within a gene to cause disease. The... Continue Reading
May 09, 2023
Harrington Discovery Institute and the American Society for Clinical Investigation seek nominations to recognize an outstanding achievement by a physician-scientist Continue Reading
May 01, 2023
Atsena Therapeutics announced that the FDA has cleared the company’s IND application for a Phase I/II clinical trial of ATSN-201 in patients with X-linked retinoschisis (XLRS), featuring Harrington Scholar Shannon Boye, PhD, University of Florida. Continue Reading
April 26, 2023
10 physician-scientists have been selected for drug development grant to advance discoveries into the clinic Continue Reading
April 14, 2023
Researchers have found a promising new method for delivering oxygen to tissues damaged by disease by coupling nitric oxide, which dilates blood vessels, with the oxygen carrying molecule hemoglobin to help people living with a number of diseases. Continue Reading
April 12, 2023
Harrington Scholar Dr. Khvorova and research team have developed a technology to deliver gene therapy directly to lung tissue through intranasal administration, a development that could potentially create a new class of treatments for lung disease. Continue Reading